Priv.-Doz. Dr. med. Andrea Formentini


  • Studium der Humanmedizin in Mailand / Italien (1986-1991)
  • Italienische Approbation und Promotion (1991)
  • Offizierarzt (Bundeswehr) (1992-1993)
  • Forschungsstipendium der Italienischen  Krebsgesellschaft  (AIRC) (1993-1995)
  • Deutsche Approbation (1995)
  • Facharzt für Chirurgie (2002)
  • Fachkunde Ösophago-Gastro-Duodenoskopie (2003)
  • Fachkunde Notarzt  / Notfallmedizin (2004)
  • Oberarzt (2005)
  • Deutsche Promotion (2007)
  • Facharzt für Viszeralchirugie (2007) und spezielle Viszeralchirugie (2011)
  • Zusatzweiterbildung Proktologie (2009)
  • Habilitation (2012)

Spezielle Schwerpunkte


  • Onkologische Chirurgie, kolorektale Chirurgie 
  • MIC
  • Proktologie / chirurgische Endoskopie 


  • Prognostische und prädiktive Faktoren gastrointestinaler Tumore


  • M2 Qualifikation (Land Baden-Württemberg)
  • Medizindidaktische Qualifikation 1 (Zertifikat Land Baden-Württemberg)
  • Leiter der Organisation, Dozent und Prüfer für das Fach Viszeralchirurgie - OTA Schule / Akademie für medizinische Berufe  Uniklinik Ulm
  • Leiter der Organisation, Dozent und Prüfer für das Fach Viszeralchirurgie - Operationsweiterbildungskurs Uniklinik Ulm
  • Dozent am Seminar „Interdisziplinäre Behandlung solider Tumore“
  • Long-term Results of Two Adjuvant Trials Reveal Differences in Chemosensitivity and the Pattern of Metastases between Colon and Rectal Cancer
    Marko Kornmann, Ludger Staib, Thomas Wiegel, Martina Kron, Doris Henne-Bruns, Karl-Heinrich Link, Andrea Formentini for the study group oncology of gastrointestinal tumors (FOGT)
    Clin Colorectal Cancer 2012, Oct 27 (Epub ahead of print)
  • Evaluation of important clinical- and pathological prognostic factors in gastric cancer
    G. Cammerer, A. Formentini (contributed equally), M. Karletshofer, D. Henne-Bruns, M. Kornmann
    Anticancer Res 2012; 32:1839-1842
  • Expression of Interleukin 4 and 13 and their receptors in colorectal cancer 
    A. Formentini, D. Henne-Bruns, M. Kornmann
    Int J Colorectal Dis. 2012; 27:1369-76. 
  • Microsatellite instability and Beta2-microglobulin mutations as prognostic markers in colorectal cancer - results of the FOGT4 trial
    Tikiclzhieva A, Benner A, Michel S, Formentini A, Link KH, Dippold W, von Knebel Doeberitz, Kornmann M, Kloor M
    Br J Cancer 2012; 106: 1239-1245
  • Zentrale Zwerchfelldefekte beim Erwachsenen – Grundlagen, Diagnosestellung, Rekonstruktionsmöglichkeiten
    Sabine Hofmann, Marko Kornmann, Doris Henne-Bruns, Andrea Formentini
    GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW 2012, Vol. 1 (Published 2012-01-09)
  • Expression of Interleukin 4 and 13 and their receptors in gastric cancer
    A. Formentini, D. Henne-Bruns, M. Kornmann
    Hepatogastroenterology (accepted 09.06.2011, in Press)
  • Thymidylatsynthase and cyclin D1 protein expression in lymphnode negative colorectal cancer: role as prognostic factors?
    A. Formentini, D. Henne-Bruns, M. Kornmann
    Hepatogastroenterology. 2012;59:1859-64.
  • Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells*
    B.Song, Y. Wang, MA. Titmus, G. Botchkina, A. Formentini, M. Kornmann, J. Ju
    Mol Cancer 2010; 9: 96
  • Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells*
    Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornamnn M, Fodstad O, Ju J.
    Oncogene 2009; 28 (46): 4065-4074
  • Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer and its expression correlates with a propensity for lymph-node metastases*
    A. Formentini, O. Prokopchuck, J. Sträter, J Kleef, LF Grochola, G leder, D. Henne-Bruns, M. Korc, M. Kornmann
    Int J Colorectal Dis 2009;  24 (1): 57 - 67
  • Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer*
    Y. Xi, A. Formentini (contributed equally), G. Nakajima, M. Kornmann, J Ju
    Oncol Rep 2008, 19 (1): 257 – 262
  • Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment
    Kornmann M, Formentini A, Ette C, Henne-Bruns D, Kron M, Sander S, Baumann W, Kreuser ED, Staib L, Link KH
    Eur J Surg Oncol 2008, 34: 1316-1321
  • Anorectal amelanotic melanoma
    A. Hillenbrand, TF Barth, D Henne-Bruns, A. Formentini
    Colorectal Dis 2008; 10 (6): 612-615
  • Rare cause of recurring necrotising pancreatitis
    Leder G, Formentini A, Hoffmann M, Henne-Bruns D
    Chirurg 2008; 79 (3): 252-257
  • Thymidylate synthase expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker?
    Formentini A , Sander S, Denzer S, Straeter J, Henne-Bruns D, Kornmann M.
    Int J Colorectal Dis 2007; 22 (1): 49-55.
  • Prognostic Values of microRNAs in Colorectal Cancer
    Xi Y, Formentini A, Chien M, Weir D, Russo J, Ju J, Kornmann M, Ju J
    Biomark Insights 2006; 2: 113-121
  • An unusual foreign body in the upper gastrointestinal tract causing nonspecific abdominal pain
    Formentini A, Stanescu A, Staib L, Aschoff AJ, Scharrer-Pamler R, Henne-Bruns D.
    Chirurg 2005; 76 (5): 501-4.
  • A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy
    Hillenbrand A, Formentini A, Staib L, Sander S, Salonga D, Danenberg K, Danenberg P, Kornmann M.
    Eur J Surg Oncol 2004; 30 (4): 407-13.
  • Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review
    Formentini A, Henne-Bruns D, Kornmann M.
    Langenbecks Arch Surg. 2004; 389 (5): 405-13. Review.
  • Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival
    Link KH, Sunelaitis E, Kornmann M, Schatz M, Gansauge F, Leder G, Formentini A, Staib L, Pillasch J, Beger HG.
    Cancer 2001; 92 (11): 2746-53.
  • Malignant transformation of intraductal-papillary mucinous tumour (IPMT) of the pancreas into infiltrating adenocarcinoma
    A. Formentini, D. Birk, G. Leder, T. Mattfeldt, J. Mueller and H.G. Beger
    HPB 2001; 3: 1-7.
  • Surgery, radio- and chemotherapy for multimodal treatment of rectal cancer
    Link KH, Staib L, Kornmann M, Formentini A, Schatz M, Suhr P, Messer P, Röttinger E, Beger HG; Forschungsgruppe Onkologie Gastrointestinale Tumoren.
    Swiss Surg  2001; 7 (6): 256-74. Review.
  • Serous cystadenocarcinoma of the pancreas and serous cystadenoma associated with ductal pancreatic adenocarcinoma
    Formentini A, Birk, D, Siech, M, Mattfeldt T, Fortnagel G, Beger, HG
    HPB 2000; 2 (1): 41-48. 
  • Kolorektale Lebermetastasen - Resektion vs. regionale Chemotherapie und sekundaere Resektion: Contra
    K.H. Link, A.Formentini, G.Leder und  H.G.Beger
    Langenbecks Arch Chir, Supplement I, Chirugisches Forum 1999; 83-88
  • Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + Folinic acid and Mitomycin C
    K.H.Link, M.Kornmann, G.Leder, A.Formentini, J.Pillasch, E. Sunelaitis, M. Schatz, J. Pressmar and H.G.Beger
    Jap J Cancer and Chemother 1999; 26: 269-281.
  • Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases
    Link KH, Pillasch J, Formentini A, Sunelaitis E, Leder G, Safi F, Kornmann M, Beger HG.
    Eur J Surg Oncol 1999; 25 (4): 381-8.
  • Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis
    Birk D, Formentini A, Lucht A, Beger HG.
    Int J Pancreatol 1999; 25 (2): 89-96.
  • "No-puncture-laparoscopy" in hernia management in childhood--reliable complement to established therapy concepts
    Birk D, Formentini A, Poch B, Beger HG.
    Chirurg 1999; 70 (3): 290-3.
  • Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional review
    Link KH, Kornmann M, Formentini A, Leder G, Sunelaitis E, Schatz M, Pressmar J, Beger HG.
    Langenbecks Arch Surg 1999; 384 (4): 344-53.
  • Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts
    Link KH, Leder G, Formentini A, Fortnagel G, Kornmann M, Schatz M, Beger HG.
    Jap J Cancer and Chemother 1999; 26 (1): 10-40. Review.
  • Resection and radiochemotherapy of pancreatic cancer--the future?
    Link KH, Formentini A, Leder G, Fortnagel G, Sartori N, Schatz M, Beger HG.
    Langenbecks Arch Surg 1998; 383 (2): 134-44. Review.
  • Systemic and regional chemotherapy, radiotherapy and combination treatments in pancreatic cancer 
    (Systemische und regionale chemotherapie strahlentherapie und kombinationsbehandlungen beim pankreaskarzinom)
    Link KH, Formentini A, Leder G, Fortnagel G, Warszawski N, Papachristou E, Lutz MB, Schoenberg MH,BegerHG
    Verdauungskrankheiten 1998, 16 (4): 189-198. 
  • Laparoskopisches “gastric banding”. Der neue Standard in der operativen Therapie des krankhaften Übergewichtes
    D.Birk, R.Kunz, B.Poch, G.Fortnagel, A. Formentini, J.G.Wechsler, H.G.Beger.
    Minimal Invasive Chirurgie 1998; 7: 83-86.
  • Small carcinoma of the pancreas. Factors of prognostic relevance
    Birk D, Fortnagel G, Formentini A, Beger HG.
    J Hepatobiliary Pancreat Surg 1998; 5 (4): 450-4.
  • The value of intraoperative laparoscopic examination of the contralateral inguinal ring during hernia repair in children
    Birk D, Formentini A, Poch B, Kunz R, Beger HG.
    J Laparoendosc Adv Surg Tech A. 1998; 8 (6): 373-9.
  • Carcinoma of the head of the pancreas arising from the uncinate process
    Birk D, Schoenberg MH, Formentini A, Fortnagel G, Beger HG.
    Br J Surg 1998; 85 (4): 498-501.
  • Inferior pancreaticoduodenal artery aneurysm as a consequence of traumatic acute pancreatitis. A case report and review of the literature
    Formentini A, Birk D, Kunz R, Orend KH, Beger HG.
    Int J Pancreatol 1997; 21 (3): 263-7.
  • Palliative, adjuvant therapeutic options in pancreatic cancer with special regard to regional chemotherapeutic options 
    Link, K.H. , Schoenberg, M.H., Staib, L., Formentini A , Leder, E., Fortnagel, G. , Warszawski, N., Lutz,M.B.Gress,Th.,Beger,H.G.
    Acta Chirurgica Austriaca 1997; 29 (5): 281-289. 
  • Regional celiac artery infusion as adjuvant treatment after pancreatic cancer resection
    Link KH, Formentini A, Papachristov E, Beger HG.
    Digestion 1997; 58 (6): 529-32.
  • Expression von C-erbB Rezeptoren, TGF alpha und p53 während der experimentellen Karzinogenese des primären Leberkarzinomes
    D.Birk, A.Formentini, A.Buck und H.G.Beger.
    Langenbecks Arch Chir, Supplement I, Chirugisches Forum 1996; 195-199.
  • Serum Konzentrazion von Epidermal Growth Factor (EGF) und Epidermal Growth Factor Receptor (EGF-R). Ein Marker für die chronische Pankreatitis, aber nicht für das Pankreaskarzinom
    Birk D, Formentini A, Lucht M, Safi F und Beger H.G.
    Langenbecks Arch Chir, Supplement I, Chirurgisches Forum 1995; 517-522.
  • Segmental duct-injected versus whole-bladder-drained pancreas transplantation: the San Raffaele Hospital experience (Milan, Italy)
    Castoldi R, Ferrari G, Staudacher C, Cristallo M, Carlucci M, Formentini A, Martinenghi S, Caldara R, La Rocca E, Secchi A
    Transpl Proc 1994; 26 (2): 450-2.
  • Emergency and pancreas transplantation
    Staudacher C, Castoldi R, Ferrari G, Formentini A, Pozza G and Di Carlo V.
    The Journal of Emergency and Intensive Care 1992, 15: 24-30.

Deutsche Gesellschaft für Chirurgie (DGC)